Who owns Elicio Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ELTX from SEC Form 13F filings across 48 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 48 institutions disclosed 3.9M shares of Elicio Therapeutics, Inc. worth $15.3M — about 14.9% of shares outstanding; the largest disclosed holder is Knoll Capital Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
48
13F holders
$15.3M
value, 2026 filers
14.9%
of shares outstanding (3.9M sh)
24
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ELTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Knoll Capital Management, LLC | 1.2M | $4.7M | 2.2% | 4.6% | +92.1% |
| 2 | BlackRock, Inc. | 766,005 | $3.0M | 0.0% | 2.9% | +1413.9% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 572,151 | $2.2M | 0.0% | 2.2% | +10.3% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 311,354 | $1.2M | 0.0% | 1.2% | +130.4% |
| 5 | STATE STREET CORP | 179,420 | $701,532 | 0.0% | 0.7% | +254.4% |
| 6 | NORTHERN TRUST CORP | 130,162 | $508,933 | 0.0% | 0.5% | +117.9% |
| 7 | Ikarian Capital, LLCNEW | 100,000 | $391,000 | 0.0% | 0.4% | new |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 88,905 | $347,619 | 0.0% | 0.3% | new |
| 9 | VANGUARD FIDUCIARY TRUST CO | 88,062 | $344,322 | 0.0% | 0.3% | +27.3% |
| 10 | ALLIANCEBERNSTEIN L.P.NEW | 81,280 | $317,805 | 0.0% | 0.3% | new |
| 11 | UBS Group AG | 40,419 | $158,039 | 0.0% | 0.2% | +19.7% |
| 12 | CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW | 31,706 | $123,970 | 0.0% | 0.1% | new |
| 13 | BOOTHBAY FUND MANAGEMENT, LLCNEW | 30,690 | $119,998 | 0.0% | 0.1% | new |
| 14 | MORGAN STANLEY | 25,546 | $99,885 | 0.0% | 0.1% | -21.2% |
| 15 | Leonteq Securities AGNEW | 20,000 | $78,200 | 0.0% | 0.1% | new |
| 16 | Nuveen, LLCNEW | 17,888 | $69,942 | 0.0% | 0.1% | new |
| 17 | CITIGROUP INCNEW | 17,726 | $69,309 | 0.0% | 0.1% | new |
| 18 | Bank of New York Mellon CorpNEW | 15,884 | $62,107 | 0.0% | 0.1% | new |
| 19 | NEW YORK STATE COMMON RETIREMENT FUNDNEW | 14,200 | $55,522 | 0.0% | 0.1% | new |
| 20 | MEYER HANDELMAN CO | 13,899 | $54,345 | 0.0% | 0.1% | 0.0% |
| 21 | HighTower Advisors, LLC | 13,666 | $53,434 | 0.0% | 0.1% | +22.4% |
| 22 | RAYMOND JAMES FINANCIAL INC | 12,720 | $49,735 | 0.0% | 0% | +14.6% |
| 23 | DEUTSCHE BANK AG\NEW | 12,652 | $49,469 | 0.0% | 0% | new |
| 24 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLCNEW | 11,972 | $41,663 | 0.0% | 0% | new |
| 25 | WELLS FARGO & COMPANY/MNNEW | 11,823 | $46,228 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.